This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Context. Vadadustat (Akebia Therapeutics) is an oral hypoxia-inducible factor prolyl-4-hydroxylase domain (HIF-PHD) inhibitor being developed for anemia in patients with…
molecule
11 months ago ●
4 mins read
In Aug. 2021, immuno-oncology company, Trillium Therapeutics, was acquired by Pfizer for $2.3 billion, adding Trillium’s two CD47-targeting biologics, TTI-621 and…
Article
2 years ago ●
3 mins read
Context. “Compound 3” (UCSF) is a covalent KRASG12R inhibitor used as a proof-of-concept for covalent arginine modification. KRAS is the…
molecule
1 year ago ●
5 mins read
Recently our non-profit partner, California Life Sciences, completed nominations for the 2021 Pantheon Award for Scientific Advancement. We’re glad to see several drug hunters…
Article
2 years ago ●
2 mins read
Context. “Compound 19” (Janssen) is an oral dihydroorotate dehydrogenase (DHODH) inhibitor being developed for acute myelogenous leukemia (AML). DHODH is…
molecule
1 year ago ●
5 mins read
Afternote: We're pleased to see Dan Erlanson made it as a finalist in the awards and Amgen's sotorasib won "Product…
Article
2 years ago ●
3 mins read
Load More
